Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell J Butterfield

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Molecular Genetics and Metabolism|August 5, 2025
Institutional readiness for novel therapeutics: A framework for multidisciplinary integrationElizabeth G Ames, Nicholas A Borja, Russell J Butterfield, et al.
Annals of Clinical and Translational Neurology|July 15, 2025
BCS1L-Associated Disease: 5'-UTR Variant Shifts the Phenotype Towards Axonal NeuropathyRotem Orbach, Nunziata Maio, Russell J Butterfield, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 30, 2025
Cardiac safety of fordadistrogene movaparvovec gene therapy in Duchenne muscular dystrophy: Initial observations from a phase 1b trialSarah P Sherlock, Daniel I Levy, Avery McIntosh, et al.
Muscle & Nerve|August 31, 2018
Modified dynamic gait index and limits of stability in myotonic dystrophy type 1Evan M Pucillo, Melissa M Mcintyre, Mary Pautler, et al.
Plos One|August 23, 2022
Novel approaches to analysis of the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD): Observations from a phase 2 trialFrancesco Muntoni, Michela Guglieri, Jean K Mah, et al.
Nature Medicine|June 27, 2025
AAV mini-dystrophin gene therapy for Duchenne muscular dystrophy: a phase 1b trialRussell J Butterfield, Perry B Shieh, Huihua Li, et al.
International Journal of Neonatal Screening|April 23, 2024
Long-Term Follow-Up Cares and Check Initiative: A Program to Advance Long-Term Follow-Up in Newborns Identified with a Disease through Newborn ScreeningMei Lietsch, Kee Chan, Jennifer Taylor, et al.
Human Mutation|September 17, 2013
Position of glycine substitutions in the triple helix of COL6A1, COL6A2, and COL6A3 is correlated with severity and mode of inheritance in collagen VI myopathiesRussell J Butterfield, A Reghan Foley, Jahannaz Dastgir, et al.
The Journal of Physiology|August 31, 2024
Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 yearsWilliam J Evans, Marc Hellerstein, Russell J Butterfield, et al.
Muscle & Nerve|April 25, 2020
Spinal muscular atrophy care in the COVID-19 pandemic eraAravindhan Veerapandiyan, Anne M Connolly, Richard S Finkel, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Molecular Genetics and Metabolism|August 5, 2025
Institutional readiness for novel therapeutics: A framework for multidisciplinary integrationElizabeth G Ames, Nicholas A Borja, Russell J Butterfield, et al.
Annals of Clinical and Translational Neurology|July 15, 2025
BCS1L-Associated Disease: 5'-UTR Variant Shifts the Phenotype Towards Axonal NeuropathyRotem Orbach, Nunziata Maio, Russell J Butterfield, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 30, 2025
Cardiac safety of fordadistrogene movaparvovec gene therapy in Duchenne muscular dystrophy: Initial observations from a phase 1b trialSarah P Sherlock, Daniel I Levy, Avery McIntosh, et al.
Muscle & Nerve|August 31, 2018
Modified dynamic gait index and limits of stability in myotonic dystrophy type 1Evan M Pucillo, Melissa M Mcintyre, Mary Pautler, et al.
Plos One|August 23, 2022
Novel approaches to analysis of the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD): Observations from a phase 2 trialFrancesco Muntoni, Michela Guglieri, Jean K Mah, et al.
Nature Medicine|June 27, 2025
AAV mini-dystrophin gene therapy for Duchenne muscular dystrophy: a phase 1b trialRussell J Butterfield, Perry B Shieh, Huihua Li, et al.
International Journal of Neonatal Screening|April 23, 2024
Long-Term Follow-Up Cares and Check Initiative: A Program to Advance Long-Term Follow-Up in Newborns Identified with a Disease through Newborn ScreeningMei Lietsch, Kee Chan, Jennifer Taylor, et al.
Human Mutation|September 17, 2013
Position of glycine substitutions in the triple helix of COL6A1, COL6A2, and COL6A3 is correlated with severity and mode of inheritance in collagen VI myopathiesRussell J Butterfield, A Reghan Foley, Jahannaz Dastgir, et al.
The Journal of Physiology|August 31, 2024
Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 yearsWilliam J Evans, Marc Hellerstein, Russell J Butterfield, et al.
Muscle & Nerve|April 25, 2020
Spinal muscular atrophy care in the COVID-19 pandemic eraAravindhan Veerapandiyan, Anne M Connolly, Richard S Finkel, et al.
Pageof 8